Abiopharma

🔍 Greco Theresa (Executive)

Company: OptimizeRx Corp (OPRX)

Report Date: 2025-08-21

Detailed Transactions and Holdings:

• Acquired 15,625 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 75,981.00 | transaction_form_type: 5 | Footnotes: F1
• Acquired 35,156 shares of Stock Option at $16.14 per share (Derivative)
  Date: 2025-08-21 | Code: A | Expires: 2030-08-21 | Exercise: 2026-08-21 | equity_swap_involved: 0 | shares_owned_after: 35,156.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
• F2: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
• REMARKS: The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.